Stockreport

Xilio Therapeutics to Present at Guggenheim Nantucket Therapeutics Conference

Xilio Therapeutics, Inc.  (XLO) 
PDF WALTHAM, Mass., Sept. 22, 2022 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a biotechnology company developing tumor-selective immuno-oncology therapies [Read more]